Guilin Layn Natural Ingredients Corp. Class A

Guilin Layn Natural Ingredients Corp. Class A

SSZSE:002166
6.46
CNY
+0.06
(+0.94%)
0.20EPS
33.43P/E
4.66BMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.95
1.31
0.99
1.12
1.83
1.44
1.4
1.37
1.87
2.27
1.99
2.43
2.78
2.8
Basic EPS, GAAP
0.08
0.09
0.15
0.14
0.47
0.19
0.2
0.15
0.21
0.29
0.11
0.22
0.19
0.19
Free Cash Flow per Basic Share
-0.78
0.1
-0.26
-0.64
0.21
-0.39
-0.42
-0.18
-0.27
-0.61
-0.42
-0.07
- -
- -
Dividend per Share
0.08
0.07
0.05
0.08
0.06
0.08
0.09
0.08
0.1
0.05
0.14
0.26
0.17
0.27
Book Value per Share
0.43
0.53
1.56
1.65
2.06
2.37
3.11
3.17
3.31
4.13
4.22
4.21
4.26
4.2
Tangible Book Value per Share
0.43
0.43
1.46
1.55
1.95
2.27
3.02
2.97
3.05
3.93
4.01
3.99
4.04
3.98
Basic Weighted Avg Shares
448
487
518
509
438
430
528
573
564
616
750
729
736
727
Sales/Revenue/Turnover
427
638
514
571
801
620
741
784
1,053
1,401
1,494
1,772
2,044
2,038
Operating Margin (%)
12.08
10.44
17.37
14.49
26.69
16.31
16.4
12.97
16.04
17.74
8.83
15.42
12.35
12.38
Depreciation Expense
17
17
18
19
25
33
36
40
56
73
88
103
131
- -
Net Income, GAAP
34
42
75
70
206
82
106
86
118
179
83
163
143
137
Effective Tax Rate (%)
18.68
3.69
11.91
14.23
16.96
13.53
14.69
12.92
13.66
21
15.48
19.56
23.83
28.3
Profit Margin (%)
8.07
6.53
14.64
12.19
25.7
13.18
14.25
10.97
11.25
12.76
5.52
9.2
7
6.7
Working Capital
210
-31
404
241
338
408
951
605
577
1,594
1,237
1,088
1,118
1,109
LT Debt
285
20
70
100
- -
- -
- -
1
2
98
65
95
75
85
Total Equity
197
239
796
846
1,051
1,211
1,755
1,809
1,901
3,113
3,204
3,201
3,240
3,198
Return on Invested Capital (%)
3.73
5.19
7.32
4.98
15.73
5.77
5.95
3.91
5.29
6.35
2.61
4.28
3.69
3.48
Return on Capital (%)
8.04
9.58
8.94
6.33
16.72
6.39
6.72
4.6
5.13
6.08
2.48
4.81
3.92
3.84
Return on Common Equity (%)
19.12
19.08
14.55
8.49
21.72
7.22
7.12
4.85
6.47
7.25
2.66
5.21
4.56
4.39

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,036
994
834
LT Borrowings
72
102
82
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
742
742
742
Market Capitalization
6,267
6,912
4,657

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,991
2,768
2,472
Cash, Cash Equivalents & STI
195
414
226
Accounts Receivable, Net
1,339
1,031
1,035
Inventories
1,317
1,197
1,099
Total Current Liabilities
1,874
1,568
1,363
Payables & Accruals
- -
- -
- -
ST Debt
1,036
994
834
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.67%
14.58%
1.22%
Free Cash Flow
-29.14%
-0.64%
-95.87%
Net Income, GAAP
25.87%
24.03%
-12.2%
Sales/Revenue/Turnover
16.2%
21.6%
15.36%
Total Cash Common Dividend
39.1%
58.89%
-36.14%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
341
384
444
602
1,772
2025
444
393
- -
772
2,044
2026
447
427
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.05
0.05
0.09
0.22
2025
0.04
0.01
- -
0.1
0.19
2026
0.06
0.02
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.22
0.02
0.01
0.26
2025
0.02
0.12
- -
0.02
0.17
2026
0.02
0.11
- -
- -
- -

Company Description

CEO
Yong Fu Xie
Full Time Employees
1,334
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
No. 19, Renmin South Road Guilin GG China 541199
IPO Date
Sep 13, 2007
Business
Guilin Layn Natural Ingredients Corp. (002166.SZ) manufactures and sells plant-based sweeteners, natural flavors, and botanical extracts primarily for food and beverage, nutraceutical, personal care, and animal nutrition applications in China and internationally. The company offers core products including stevia extracts such as SteviUp M2, a next-generation Reb M sweetener with sugar-like taste and superior solubility; monk fruit extracts with elevated Mogroside-V content; tea extracts including green tea from its Wagott subsidiary; lovia; and other plant extracts like rhodiola, cranberry, magnolia bark, ginkgo biloba, and beta-glucans such as Galacan for immune and microbiome health; these are marketed under brands Plantae for food and beverage ingredients, Nutrae for supplements and personal care, and TruGro for pet and animal nutrition. Founded in 1995 and headquartered in Guilin, China, with key facilities including a fourth-generation extraction plant, global innovation centers, and subsidiaries in the USA (Indiana and California), Europe (Italy), and Latin America, the company went public on the Shenzhen Stock Exchange in 2007 as the first in China's botanical extract industry. Recent developments include the 2025 launch of enzyme-based NMN via precision fermentation for healthy aging, alongside a multi-year monk fruit contract program for supply stability; expansion of U.S. production with Indiana factory upgrades to enhance competitiveness amid tariff exemptions for over 85% of its natural sweeteners exported to the USA; new feed additives with water-soluble polyphenols for poultry and swine showcased at IPPE 2025; and deepened partnerships with global clients like Firmenich, projected to deliver $136 million in annual orders through 2028, supporting biotechnology investments and production capacity growth.